MeMed’s host response technology decodes the complex signals of our immune system into actionable insights. These can be used to transform the way infectious diseases are diagnosed and treated.
MeMed BV® is an FDA-cleared host-immune response assay that can aid to distinguish between bacterial and viral infections, delivering faster, easier and accurate results in 15 minutes from a serum sample. MeMed BV performance was validated in multiple multinational, double-blind clinical studies and real-world usage encompassing >20,000 patients and is CE-marked and FDA cleared.
Utilizing the human immune system as a sensor, MeMed BV runs on MeMed Key®, a pioneering benchtop analyzer that brings high analytical performance to the point of need.